DISOPYRAMIDE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Disopyramide Phosphate, and what generic alternatives are available?
Disopyramide Phosphate is a drug marketed by Nesher Pharms, Dr Reddys Labs Sa, Interpharm, Ivax Sub Teva Pharms, Mylan, Rising, Sun Pharm Industries, Superpharm, Teva, and Watson Labs. and is included in eighteen NDAs.
The generic ingredient in DISOPYRAMIDE PHOSPHATE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Disopyramide Phosphate
A generic version of DISOPYRAMIDE PHOSPHATE was approved as disopyramide phosphate by TEVA on February 22nd, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DISOPYRAMIDE PHOSPHATE?
- What are the global sales for DISOPYRAMIDE PHOSPHATE?
- What is Average Wholesale Price for DISOPYRAMIDE PHOSPHATE?
Summary for DISOPYRAMIDE PHOSPHATE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 18 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 46 |
Clinical Trials: | 1 |
What excipients (inactive ingredients) are in DISOPYRAMIDE PHOSPHATE? | DISOPYRAMIDE PHOSPHATE excipients list |
DailyMed Link: | DISOPYRAMIDE PHOSPHATE at DailyMed |
Recent Clinical Trials for DISOPYRAMIDE PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Oxford | N/A |
University of Aberdeen | N/A |
Pharmacology for DISOPYRAMIDE PHOSPHATE
Drug Class | Antiarrhythmic |